|
The Hymed Group Corporation
|
|
|
hyCURE® - Medical Hydrolysate of Type I Collagen
CASE STUDY: A.Z., 77 year old white female. Did not know she was diabetic. Admitted 1/29/97 with gangrenous right great toe and purple discoloration of entire foot except for 4 remaining toes. 1/29/97, 1/30/97, 1/31/97 Underwent debridement. Had amputation of first great toe on 2/3/97, with debridement of forefoot; wound almost 50% of length of foot, with 3 tendons of toes exposed on dorsal surface. 2/5/97 Started Mesalt to wound. 2/6/97 Went to extended care facility. 2/7/97 Area over tendon measured 7.5 cm long x 3.6 cm wide. 2/11/97 Mesalt stopped and hyCURE® started to wound at dorsum of foot. Mesalt used on plantar surface to continue debridement of thick yellow eschar. 2/12/97 Increased granulation tissue noted on dorsum wound bed. 2/17/97 Saw improvement with tissue covering tendons. 2/21/97 Grafting performed over tendons and closure of plantar area of foot. "hyCURE® worked to promote the deposition of tissue over tendons to allow the physician to graft the site." Edna Keister, BBA, RN, CETN, OCN |
|
Send mail to Anita Petito with
questions or comments about this web site.
|